Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study.

Kazuhito Misawa Kageaki WatanabeMasahiro SeikeYukio Hosomi

Published in: Translational lung cancer research (2024)

Durvalumab plus PE in patients with ES-SCLC showed good efficacy and safety according to our real-world data, suggesting that this treatment is well tolerated in clinical practice, even in elderly patients and those with poor PS.

Keyphrases

small cell lung cancer
clinical practice
electronic health record
squamous cell carcinoma
brain metastases
combination therapy
data analysis
replacement therapy
rectal cancer
smoking cessation